Literature DB >> 22787205

HIV-1 induces telomerase activity in monocyte-derived macrophages, possibly safeguarding one of its reservoirs.

Rita Reynoso1, Matthias Wieser, Diego Ojeda, Maximilian Bönisch, Harald Kühnel, Federico Bolcic, Heribert Quendler, Johannes Grillari, Regina Grillari-Voglauer, Jorge Quarleri.   

Abstract

Monocyte-derived macrophages (MDM) are widely distributed in all tissues and organs, including the central nervous system, where they represent the main part of HIV-infected cells. In contrast to activated CD4(+) T lymphocytes, MDM are resistant to cytopathic effects and survive HIV infection for a long period of time. The molecular mechanisms of how HIV is able to persist in macrophages are not fully elucidated yet. In this context, we have studied the effect of in vitro HIV-1 infection on telomerase activity (TA), telomere length, and DNA damage. Infection resulted in a significant induction of TA. This increase was directly proportional to the efficacy of HIV infection and was found in both nuclear and cytoplasmic extracts, while neither UV light-inactivated HIV nor exogenous addition of the viral protein Tat or gp120 affected TA. Furthermore, TA was not modified during monocyte-macrophage differentiation, MDM activation, or infection with vaccinia virus. HIV infection did not affect telomere length. However, HIV-infected MDM showed less DNA damage after oxidative stress than noninfected MDM, and this resistance was also increased by overexpressing telomerase alone. Taken together, our results suggest that HIV induces TA in MDM and that this induction might contribute to cellular protection against oxidative stress, which could be considered a viral strategy to make macrophages better suited as longer-lived, more resistant viral reservoirs. In the light of the clinical development of telomerase inhibitors as anticancer therapeutics, inhibition of TA in HIV-infected macrophages might also represent a novel therapeutic target against viral reservoirs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22787205      PMCID: PMC3457250          DOI: 10.1128/JVI.01495-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  84 in total

1.  Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions.

Authors:  C Bachor; O A Bachor; P Boukamp
Journal:  J Cancer Res Clin Oncol       Date:  1999 Aug-Sep       Impact factor: 4.553

2.  Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.

Authors:  J P Lai; W Z Ho; G X Zhan; Y Yi; R G Collman; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Comparison of early passage, senescent and hTERT immortalized endothelial cells.

Authors:  Martina Wei-Fen Chang; Johannes Grillari; Corina Mayrhofer; Klaus Fortschegger; Günter Allmaier; Gorji Marzban; Hermann Katinger; Regina Voglauer
Journal:  Exp Cell Res       Date:  2005-09-10       Impact factor: 3.905

4.  Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors.

Authors:  Mathias Lichterfeld; Danlei Mou; Thai Duong Hong Cung; Katie L Williams; Michael T Waring; Jinghe Huang; Florencia Pereyra; Alicja Trocha; Gordon J Freeman; Eric S Rosenberg; Bruce D Walker; Xu G Yu
Journal:  Blood       Date:  2008-08-26       Impact factor: 22.113

Review 5.  Antiretroviral therapy in macrophages: implication for HIV eradication.

Authors:  Christina Gavegnano; Raymond F Schinazi
Journal:  Antivir Chem Chemother       Date:  2009-10-19

6.  HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.

Authors:  Tulin Otamis Price; Nuran Ercal; Ryota Nakaoke; William A Banks
Journal:  Brain Res       Date:  2005-04-19       Impact factor: 3.252

7.  Constitutive activation of phosphatidylinositol 3-kinase signaling pathway down-regulates TLR4-mediated tumor necrosis factor-alpha release in alveolar macrophages from asymptomatic HIV-positive persons in vitro.

Authors:  Souvenir D Tachado; Xin Li; Katharine Swan; Naimish Patel; Henry Koziel
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

8.  Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707.

Authors:  Judith Haendeler; Jörg Hoffmann; Ralf P Brandes; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

9.  Telomere length measurement by a novel monochrome multiplex quantitative PCR method.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

10.  Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy.

Authors:  Pauline Chugh; Birgit Bradel-Tretheway; Carlos M R Monteiro-Filho; Vicente Planelles; Sanjay B Maggirwar; Stephen Dewhurst; Baek Kim
Journal:  Retrovirology       Date:  2008-01-31       Impact factor: 4.602

View more
  18 in total

Review 1.  Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs.

Authors:  Tiffany A Peterson; Andrew G MacLean
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-13       Impact factor: 4.147

2.  CD4+ memory T cells infected with latent HIV-1 are susceptible to drugs targeting telomeres.

Authors:  Dorota Piekna-Przybylska; Sanjay B Maggirwar
Journal:  Cell Cycle       Date:  2018-09-20       Impact factor: 4.534

Review 3.  Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.

Authors:  Dionna W Williams; Mike Veenstra; Peter J Gaskill; Susan Morgello; Tina M Calderon; Joan W Berman
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

Review 4.  Aging and HIV/AIDS: pathogenetic role of therapeutic side effects.

Authors:  Rebecca A Torres; William Lewis
Journal:  Lab Invest       Date:  2013-12-16       Impact factor: 5.662

Review 5.  Gastrointestinal tract and the mucosal macrophage reservoir in HIV infection.

Authors:  Dallas Brown; Joseph J Mattapallil
Journal:  Clin Vaccine Immunol       Date:  2014-09-03

6.  Deficiency in DNA damage response, a new characteristic of cells infected with latent HIV-1.

Authors:  Dorota Piekna-Przybylska; Gaurav Sharma; Sanjay B Maggirwar; Robert A Bambara
Journal:  Cell Cycle       Date:  2017-04-07       Impact factor: 4.534

7.  Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing.

Authors:  Jennifer N Rainho; Mauricio A Martins; Francesc Cunyat; Ian T Watkins; David I Watkins; Mario Stevenson
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

8.  HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses.

Authors:  Kiera L Clayton; Geetha Mylvaganam; Alonso Villasmil-Ocando; Heather Stuart; Marcela V Maus; Mohammad Rashidian; Hidde L Ploegh; Bruce D Walker
Journal:  Cell Host Microbe       Date:  2021-02-10       Impact factor: 21.023

9.  Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy.

Authors:  Tianyuzi Li; Howard E Gendelman; Gang Zhang; Pavan Puligujja; JoEllyn M McMillan; Tatiana K Bronich; Benson Edagwa; Xin-Ming Liu; Michael D Boska
Journal:  Int J Nanomedicine       Date:  2015-06-03

Review 10.  Macrophages and their relevance in Human Immunodeficiency Virus Type I infection.

Authors:  Herwig Koppensteiner; Ruth Brack-Werner; Michael Schindler
Journal:  Retrovirology       Date:  2012-10-04       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.